WHC is still in active development. Read this to understand our approach.
depiction of JOFWLTCLBGQGBO-UHFFFAOYSA-N.svg
tripsit

triazolam

Verificar en tripsit

psychonaut

Triazolam

Verificar en psychonaut

isomerdesign

Triazolam

Verificar en isomerdesign

pubchem

Triazolam

Verificar en pubchem

drugmap

Triazolam

Verificar en drugmap

Data

InChI: InChI=1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3

Sinónimos: SCHEMBL29228,DSSTox_RID_81886,Triazolam, European Pharmacopoeia (EP) Reference Standard, U33,030,SMR000058837,Triazolam 1.0 mg/ml in Methanol, Apo Triazo,8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]-benzodiazepine,DTXSID6046763, 8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine,TRIAZOLAM [JAN],Hypnostat, 8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine,CCRIS 1932,TRIAZOLAM [USP MONOGRAPH],Halcion (triazolam), Gen Triazolam,Triazolam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Apo-Triazo,8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine,1HM943223R,DEA No. 2887,D00387,Clorazolam,CHEMBL646,BRN 1226643,TRIAZOLAM [MART.], Apotex Brand of Triazolam,Triazolamum [INN-Latin],4H-s-Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(o-chlorophenyl)-1-methyl-, Triazolam Pfizer Brand,N05CD05,28911-01-5, Halcion (TN),DSSTox_CID_26763, Alti-Triazolam,DB00897,TRIAZOLAM [USAN],TGAR01H, 8-Chloro-6-[2-chlorophenyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine,L000796,SR-01000937604-2,(E)-8-chloro-6-(2-chlorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine,UNII-1HM943223R,Songar,BDBM50001765,8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine,4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-methyl-, 8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine,TRIAZOLAM [HSDB], Gen-Triazolam,Triazolam (JAN/USP/INN),28911-01-5 (free),8-chloro-1-methyl-6-(o-chlorophenyl)-4H-s-triazolo-[4,3-a][1,4] benzodiazepine,TRIAZOLAM CIV [USP-RS],8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-1,2,4-triazolo[4,3-a][1,4]benzodiazepine, Triazolam [USAN:BAN:INN:JAN],8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine,U 33030,HSDB 6759, Novidorm,GTPL7313,DSSTox_GSID_46763,12-chloro-9-(2-chlorophenyl)-3-methyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene,8-chloro-6-(2-chlorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine,ZINC2212,Triazolam 0.1 mg/ml in Methanol,triazolam,U33030, Apo-Triazo (TN),halcion,TRIAZOLAM [VANDF],TRIAZOLAM [WHO-DD],CHEBI:9674, Hypnostat,TRIAZOLAM [MI], 8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine,SR-01000937604,TRIAZOLAM [ORANGE BOOK],U-33030, Triazolamum,Triazolam civ, U-33030,4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-methyl-,Halcion, Triazolam (JAN/USP/INN),Trilam, Trilam (TN), Hypam (TN), Halcion (triazolam),MLS003899243,911T015, Songar, TGAR01H, U 33,030, Halcion,8-chloro-1-methyl-6-(o-chlorophenyl)-4H-s-triazolo[4,3-a][1,4]benzodiazepine, Genpharm Brand of Triazolam,Triazolam,Halcion (TN),Q412143, Novo-Triolam,Triazolam [USAN:USP:INN:BAN:JAN], U-33,030, Triazolamum [INN-Latin], Pfizer Brand of Triazolam,Hypam,Triazolamum, U 33030,Novidorm,Tox21_112617,NCGC00168258-01,CAS-28911-01-5, Trilam,8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine, Novodorm,HY-B0694, Gerard Brand of Triazolam,TRIAZOLAM [INN],EINECS 249-307-3,U-33,030,Novodorm


Estimated data

Solubilidad: -6.782 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 74.7% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.